News Release

May 7, 2024

Raised funds through a third-party allocation of new shares from Keio Innovation Initiative, Inc.

PURMX Therapeutics, Inc. (PURMX Therapeutics; Headquarters: Hiroshima, Japan; President: Hidetoshi Tahara; hereafter “the Company”) is...

Nov 30, 2023

We are pleased to announce that PURMX Therapeutics, Inc. (headquartered in Hiroshima City, Japan; Hidetoshi Tahara, President & CEO;...

Sep 8, 2022

PURMX Therapeutics (headquartered in Hiroshima, Japan; Hidetoshi Tahara, President & CEO; hereinafter referred to as "the Company") has...